CN104922081B - 一种盐酸千金藤碱冻干粉、制备方法及其应用 - Google Patents
一种盐酸千金藤碱冻干粉、制备方法及其应用 Download PDFInfo
- Publication number
- CN104922081B CN104922081B CN201510274608.8A CN201510274608A CN104922081B CN 104922081 B CN104922081 B CN 104922081B CN 201510274608 A CN201510274608 A CN 201510274608A CN 104922081 B CN104922081 B CN 104922081B
- Authority
- CN
- China
- Prior art keywords
- freeze
- dried powder
- parts
- cepharantin hydrochloride
- cepharantin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title claims abstract description 88
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 title claims abstract description 71
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 title claims abstract description 71
- 239000000843 powder Substances 0.000 title claims abstract description 68
- 238000002360 preparation method Methods 0.000 title claims description 21
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims abstract description 20
- 239000008101 lactose Substances 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 19
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 14
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 14
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 14
- 239000008215 water for injection Substances 0.000 claims abstract description 9
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims abstract description 6
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims description 22
- 239000000047 product Substances 0.000 claims description 16
- 239000007924 injection Substances 0.000 claims description 12
- 238000002347 injection Methods 0.000 claims description 12
- 239000002994 raw material Substances 0.000 claims description 11
- 238000003756 stirring Methods 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- UEAPAHNNFSZHMW-UHFFFAOYSA-N stepahnine Natural products COC1=CC=CC(C2=C34)=C1CC3N(C)CCC4=CC1=C2OCO1 UEAPAHNNFSZHMW-UHFFFAOYSA-N 0.000 claims description 9
- UEAPAHNNFSZHMW-CQSZACIVSA-N stephanine Chemical compound CN([C@@H]1CC2=C(C3=C11)C=CC=C2OC)CCC1=CC1=C3OCO1 UEAPAHNNFSZHMW-CQSZACIVSA-N 0.000 claims description 9
- 238000004108 freeze drying Methods 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 7
- 238000011049 filling Methods 0.000 claims description 7
- 239000000706 filtrate Substances 0.000 claims description 7
- 239000003643 water by type Substances 0.000 claims description 7
- 239000003513 alkali Substances 0.000 claims description 5
- 239000012982 microporous membrane Substances 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 9
- 238000004090 dissolution Methods 0.000 abstract description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 3
- 229940079593 drug Drugs 0.000 abstract description 3
- 229940093181 glucose injection Drugs 0.000 abstract description 3
- 239000008354 sodium chloride injection Substances 0.000 abstract description 3
- 239000013618 particulate matter Substances 0.000 abstract description 2
- 229940090044 injection Drugs 0.000 description 10
- 238000012360 testing method Methods 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 241000195493 Cryptophyta Species 0.000 description 6
- 241000345998 Calamus manan Species 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 235000012950 rattan cane Nutrition 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000009413 insulation Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- BJWWOUUGCAPHOV-UHFFFAOYSA-N 1,3-dibenzylisoquinoline Chemical group C=1C2=CC=CC=C2C(CC=2C=CC=CC=2)=NC=1CC1=CC=CC=C1 BJWWOUUGCAPHOV-UHFFFAOYSA-N 0.000 description 1
- 241001411320 Eriogonum inflatum Species 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 241000218164 Menispermaceae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000003038 endothelium Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 210000000777 hematopoietic system Anatomy 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000006101 laboratory sample Substances 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510274608.8A CN104922081B (zh) | 2015-05-27 | 2015-05-27 | 一种盐酸千金藤碱冻干粉、制备方法及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510274608.8A CN104922081B (zh) | 2015-05-27 | 2015-05-27 | 一种盐酸千金藤碱冻干粉、制备方法及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104922081A CN104922081A (zh) | 2015-09-23 |
CN104922081B true CN104922081B (zh) | 2017-11-21 |
Family
ID=54109744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510274608.8A Active CN104922081B (zh) | 2015-05-27 | 2015-05-27 | 一种盐酸千金藤碱冻干粉、制备方法及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104922081B (zh) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1875945A (zh) * | 2006-05-09 | 2006-12-13 | 广州暨南生物医药研究开发基地有限公司 | 盐酸千金藤碱冻干粉针剂及其制备方法 |
CN101507725A (zh) * | 2008-12-31 | 2009-08-19 | 河南省医药科学研究院 | 千金藤碱及其盐酸盐在制备抗乙肝病毒药物中的应用 |
CN101891750B (zh) * | 2010-05-06 | 2013-04-17 | 中国科学院昆明植物研究所 | 千金藤碱及其盐的制备方法 |
-
2015
- 2015-05-27 CN CN201510274608.8A patent/CN104922081B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104922081A (zh) | 2015-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11351184B2 (en) | Preparation of Pulsatilla saponin B4 for injection | |
CN105434373B (zh) | 一种注射用奥拉西坦冻干制剂及其制备方法 | |
CN108938654B (zh) | 一种白头翁皂苷b4的注射用制剂 | |
CN101716176A (zh) | 一种注射用右兰索拉唑及其制备方法 | |
CN105078905A (zh) | 一种注射用盐酸多西环素冻干粉针剂的制备方法 | |
CN102525963A (zh) | 一种硫酸奈替米星冻干粉针及其制备方法 | |
CN103860483A (zh) | 复方甘草酸苷类冻干粉针注射剂及其制备方法 | |
CN103961322B (zh) | 一种注射用右旋兰索拉唑冻干组合物及其制备方法 | |
CN104922081B (zh) | 一种盐酸千金藤碱冻干粉、制备方法及其应用 | |
CN102670524B (zh) | 一种注射用泮托拉唑钠冻干制剂及其制备方法 | |
CN103980279B (zh) | 一种甲氨蝶呤化合物及注射用甲氨蝶呤 | |
CN102488663A (zh) | 一种二乙酰氨乙酸乙二胺药物组合物及其制备方法 | |
CN103230373A (zh) | 一种注射用右兰索拉唑冻干粉及其制备方法 | |
TW201417825A (zh) | 含有抗真菌藥物和乳酸鹽緩衝劑的組成物 | |
CN106389359A (zh) | 供注射用的贝利司他药物组合物及其制备方法 | |
CN107638561B (zh) | 一种鲎素肽在制备防治肺纤维化药物中的应用 | |
CN106074399B (zh) | 一种帕瑞昔布钠冻干制剂及其制备方法 | |
CN105748414A (zh) | 抗感染米卡芬净冻干组合物及其制备方法 | |
CN107998084B (zh) | 一种兰索拉唑冻干粉及其制备方法 | |
CN108992672B (zh) | 一种治疗肿瘤病的汉黄芩素药物组合物 | |
CN107281122A (zh) | 一种左旋奥拉西坦冻干粉针及其制备方法 | |
CN104510708B (zh) | 一种米铂冻干制剂及其制备方法 | |
CN107281120A (zh) | 一种左旋奥拉西坦冻干粉针及其制备方法 | |
CN104922677A (zh) | 一种含盐酸千金藤碱的药物组合物在制备治疗白细胞减少的药物中的应用 | |
CN105055347A (zh) | 一种治疗转移性结直肠癌的药物奥沙利铂组合物冻干粉针剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20151130 Address after: 510520, Guangzhou, Guangdong province Tianhe District hi tech Road, No. 32, No. 34, block B1, South Building, 4 floor, East Applicant after: GUANGZHOU SALIAI STEMCELL SCIENCE AND TECHNOLOGY Co.,Ltd. Address before: South 5 building 510632 Guangdong city of Guangzhou province Tianhe District Whampoa Road West, No. 601 Jinan University College of life science and technology Applicant before: Guangzhou Jinan Biomedical Research and Development center |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 510032 -29, No. 339 Heng Jiang Road, Conghua suburb street, Guangzhou, Guangdong (first floor, A factory). Patentee after: GUANGZHOU SALIAI STEMCELL SCIENCE AND TECHNOLOGY Co.,Ltd. Address before: 510520 east 4 floor, B1 south tower, 32 and 34, Tianhe District high tech Road, Guangzhou, Guangdong. Patentee before: GUANGZHOU SALIAI STEMCELL SCIENCE AND TECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 510320 unit 403a, 4th floor, production area, No. 1, helix 4th Road, International Biological Island, Huangpu District, Guangzhou, Guangdong Province Patentee after: Guangzhou kangqilai precision medical technology Co.,Ltd. Address before: 510032 -29, No. 339 Heng Jiang Road, Conghua suburb street, Guangzhou, Guangdong (first floor, A factory). Patentee before: GUANGZHOU SALIAI STEMCELL SCIENCE AND TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220727 Address after: 510610 room 4105, No. 365, Tianhe North Road, Tianhe District, Guangzhou, Guangdong Province (office only) Patentee after: Guangzhou Shaobo Holding Group Co.,Ltd. Address before: 510320 unit 403a, 4th floor, production area, No. 1, helix 4th Road, International Biological Island, Huangpu District, Guangzhou, Guangdong Province Patentee before: Guangzhou kangqilai precision medical technology Co.,Ltd. |